Behavioral synergism between D1 and D2 dopamine receptors in mice does not depend on gap junctions

Synapse

Volumn 61, Issue 5, 2007, Pages 279-287

  Nolan, Eileen B ^a   Harrison, Laura M ^a   Lahoste, Gerald J ^a   Ruskin, David N ^a  

^a UNIVERSITY OF NEW ORLEANS   (United States)

Author keywords

Apomorphine; Carbenoxolone; Connexin 36; Eticlopride; Grooming; Mefloquine; Octanol; SCH 23390; Stereotypy

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; APOMORPHINE; CARBENOXOLONE; CONNEXIN 36; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; ETICLOPRIDE; MEFLOQUINE; OCTANOL;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; GAP JUNCTION; GENOTYPE; LICKING; MALE; MASTICATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SNIFFING; STEREOTYPY;

ANIMALS; APOMORPHINE; CARBENOXOLONE; CONNEXINS; CORPUS STRIATUM; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; GAP JUNCTIONS; MEFLOQUINE; MICE; MICE, TRANSGENIC; OCTANOLS; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SALICYLAMIDES; STEREOTYPED BEHAVIOR;

EID: 33947161046     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20371     Document Type: Article

References (55)

1. Allison DW, Ohran AJ, Stobbs SH, Mameli M, Valenzuela CF, Sudweeks SN, Ray AP, Henriksen SJ, Steffensen SC. 2006. Connexin-36 gap junctions mediate electrical coupling between ventral tegmental area GABA neurons. Synapse 60:20-31.
2. Baudry S, Pham YT, Baune B, Vidrequin S, Crevoisier C, Gimenez F, Farinotti R. 1997. Stereoselective passage of mefloquine through the blood-brain barrier in the rat. J Pharm Pharmacol 49: 1086-1090.
3. Belluardo N, Mudò G, Trovato-Salinaro A, Le Gurun S, Charollais A, Serre-Beinier V, Amato G, Haefliger J-A, Meda P, Condorelli DF. 2000. Expression of connexin36 in the adult and developing rat brain. Brain Res 865:121-138.
4. 2 agonists in intact rats. Brain Res 504:276-283.
5. Braun AR, Chase TN. 1986. Obligatory D-1/D-2 receptor interaction in the generation of dopamine agonist related behaviors. Eur J Pharmacol 131:301-306.
6. Breese GR, Mueller RA. 1985. SCH-23390 antagonism of a D-2 dopamine agonist depends upon catecholaminergic neurons. Eur J Pharmacol 113:109-114.
7. Brocks DR, Mehvar R. 2003. Stereoselectivity in the pharmacodynamics and pharmacokinetics of the chiral antimalarial drugs. Clin Pharmacokinet 42:1359-1382.
8. Bruzzone R, Barbe MT, Jakob NJ, Monyer H. 2005. Pharmacological properties of homomeric and heteromeric pannexin hemichannels expressed in Xenopus oocytes. J Neurochem 92:1033-1043.
9. Christensen AV, Arnt J, Hyttel J, Svendsen O. 1984. Behavioural correlates to the dopamine D-1 and D-2 antagonists. Pol J Pharmacol Pharm 36:249-264.
10. Christie JM, Bark C, Hormuzdi SG, Helbig I, Monyer H, Westbrook GL. 2005. Connexin36 mediates spike synchrony in olfactory bulb glomeruli. Neuron 46:761-772.
11. 2 dopamine receptor. Neuropharmacology 39:382-390.
12. 2 dopamine receptor "knockout." Neuropsychopharmacology 25: 527-536.
13. Condorelli DF, Parenti R, Spinella F, Salinaro AT, Belluardo N, Cardile V, Cicirata F. 1998. Cloning of a new gap junction gene (Cx36) highly expressed in mammalian brain neurons. Eur J Neurosci 10:1202-1208.
14. Condorelli DF, Belluardo N, Trovato-Salinaro A, Mudò G. 2000. Expression of cx36 in mammalian neurons. Brain Res Rev 32:72-85.
15. Cruikshank SJ, Hopperstad M, Younger M, Connors BW, Spray DC, Srinivas M. 2004. Potent block of Cx36 and Cx50 gap junction channels by mefloquine. Proc Natl Acad Sci USA 101:12364-12369.
16. 1 dopamine receptor agonist. Neuropsychopharmacology 5:187-195.
17. De Zeeuw CI, Chorev E, Devor A, Manor Y, Van Der Giessen RS, De Jeu MT, Hoogenraad CC, Bijman J, Ruigrok TJH, French P, Jaarsma D, Kistler WM, Meier C, Petrasch-Parwez E, Dermietzel R, Söhl G, Gueldenagel M, Willecke K, Yarom Y. 2003. Deformation of network connectivity in the inferior olive of connexin 36-deficient mice is compensated by morphological and electrophysiological changes at the single neuron level. J Neurosci 23:4700-4711.
18. Deans MR, Gibson JR, Sellitto C, Connors BW, Paul DL. 2001. Synchronous activity of inhibitory networks in neocortex requires electrical synapses containing connexin36. Neuron 31:477-485.
19. Deans MR, Volgyi B, Goodenough DA, Bloomfield SA, Paul DL. 2002. Connexin36 is essential for transmission of rod-mediated visual signals in the mammalian retina. Neuron 36:703-712.
20. Deng Y-P, Lei W-L, Reiner A. Differential perikaryal localization in rats of D1 and D2 dopamine receptors on striatal projection neuron types identified by retrograde labeling. J Chem Neuroanat 32:101-116.
21. 1-like" dopamine receptor agonists. Pharmacol Biochem Behav 58:551-558.
22. Dziewczapolski G, Menalled LB, Garcia MC, Mora MA, Gershanik OS, Rubenstein M. 1998. Opposite roles of D1 and D5 dopamine receptors in locomotion revealed by selective antisense oligonucleotides. NeuroReport 9:1-5.
23. Ernst AM. 1967. Mode of action of apomorphine and dexamphetamine on gnawing compulsion in rats. Psychopharmacologia 10:316-323.
24. Frisch C, De Souza-Silva MA, Söhl G, Güldenagel M, Willecke K, Huston JP, Dere E. 2005. Stimulus complexity dependent memory impairment and changes in motor performance after deletion of the neuronal gap junction protein connexin36 in mice. Behav Brain Res 157:177-185.
25. Güldenagel M, Ammermüller J, Feigenspan A, Teubner B, Degen J, Söhl G, Willecke K, Weiler R. 2001. Visual transmission deficits in mice with targeted disruption of the gap junction gene connexin36. J Neurosci 21:6036-6044.
26. Gustafson N, Gireesh-Dharmaraj E, Czubayko U, Blackwell KT, Plenz D. 2006. A comparative voltage and current-clamp analysis of feedback and feedforward synaptic transmission in the striatal microcircuit in vitro. J Neurophysiol 95:737-752.
27. Honda F, Satoh Y, Shimomura K, Satoh H, Noguchi H, Uchida S, Kato R. 1977. Dopamine receptor blocking activity of sulpiride in the central nervous system. Jpn J Pharmacol 27:397-411.
28. Hormuzdi SG, Filippov MA, Mitropoulou G, Monyer H, Bruzzone R. 2004. Electrical synapses: A dynamic signaling system that shapes the activity of neuronal networks. Biochim Biophys Acta 1662:113-137.
29. Kiehn O, Tresch MC. 2002. Gap junctions and motor behavior. Trends Neurosci 25:108-115.
30. Kita H, Kosaka T, Heizmann CW. 1990. Parvalbumin-immunoreactive neurons in the rat neostriatum: A light and electron microscopic study. Brain Res 536:1-15.
31. Koós T, Tepper JM. 1999. Inhibitory control of neostriatal projection neurons by GABAergic interneurons. Nat Neurosci 2:467-472.
32. 2 synergism are unrelated to changes in striatal receptor density. Synapse 12:14-26.
33. LaHoste GJ, Marshall JF. 1996. Dopamine receptor interactions in the brain. In: Stone TW, editor. CNS neurotransmitters and neuromodulators: Dopamine. Boca Raton, FL: CRC Press. p 107-119.
34. LaHoste GJ, Yu J, Marshall JF. 1993. Striatal fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity. Proc Natl Acad Sci USA 90:7451-7455.
35. 4, receptors in the striatum without the involvement of action potentials. J Neurosci 20:6666-6671.
36. Leshchenko Y, Likhodii S, Yue W, Burnham WM, Perez Velazquez J-L. 2006. Carbenoxolone does not cross the blood brain barrier: An HPLC study. BMC Neurosci 7:3.
37. Martin FC, Handforth A. Carbenoxolone and mefloquine suppress tremor in the harmaline mouse model of essential tremor. Mov Disord 21:1641-1649.
38. Maxeiner S, Krüger O, Schilling K, Traub O, Urschel S, Willecke K. 2003. Spatiotemporal transcription of connexin45 during brain development results in neuronal expression in adult mice. Neuroscience 119:689-700.
39. McCracken CB, Hamby SM, Patel KM, Morgan D, Vrana KE, Roberts DCS. 2005a. Extended cocaine self-administration and deprivation produces region-specific and time-dependent changes in connexin36 expression in rat brain. Synapse 58:141-150.
40. McCracken CB, Patel KM, Vrana KE, Paul DL, Roberts DCS. 2005b. Amphetamine withdrawal produces region-specific and time-dependent changes in connexin36 expression in rat brain. Synapse 56:39-44.
41. 3 dopamine receptor "knockout". Synapse 46:13-31.
42. 1 antagonist SCH 23390. Psychopharmacologia 82:409-410.
43. Moore H, Grace AA. 2002. A role for electrotonic coupling in the striatum in the expression of dopamine receptor-mediated stereotypies. Neuropsychopharmacology 27:980-992.
44. Neisewander JL, Ong A, McGonigle P. 1995. Anatomical localization of SKF-38393-induced behaviors in rats using the irreversible monoamine receptor antagonist EEDQ. Synapse 19:134-143.
45. Onn S-P, Grace AA. 1994. Dye coupling between rat striatal neurons recorded in vivo: Compartmental organization and modulation by dopamine. J Neurophysiol 71:1917-1934.
46. Onn S-P, Grace AA. 1999. Alterations in electrophysiological activity and dye coupling of striatal spiny and aspiny neurons in dopamine-denervated rat striatum recorded in vivo. Synapse 33:1-15.
47. 2-like interactions. Synapse 55:201-211.
48. 1-like interactions. Synapse 59:107-118.
49. 2 receptors regulating rat locomotor activity. Psychopharmacology 99:558-562.
50. Rajakumar N, Laurier L, Niznik HB, Stoessl AJ. 1997. Effects of intrastriatal infusion of D2 receptor antisense oligonucleotide on apomorphine-induced behaviors in the rat. Synapse 26:199-208.
51. Rash JE, Staines WA, Yasamura T, Patel D, Furman CS, Stelmack GL, Nagy JI. 2000. Immunogold evidence that neuronal gap junctions in adult rat brain and spinal cord contain connexin-36 but not connexin-32 or connexin-43. Proc Natl Acad Sci USA 97:7573-7578.
52. Rash JE, Yasumura T, Davidson K, Furman CS, Dudek FE, Nagy JI. 2001. Identification of cells expressing Cx43, Cx30, Cx26, Cx32 and Cx36 in gap junctions of rat brain and spinal cord. Cell Commun Adhes 8:315-320.
53. Söhl G, Degen J, Teubner B, Willecke K. 1998. The murine gap junction gene connexin36 is highly expressed in mouse retina and regulated during brain development. FEBS Lett 428:27-31.
54. White FJ, Bednarz LM, Wachtel SR, Hjorth S, Brooderson RJ. 1988. Is stimulation of both D1 and D2 receptors necessary for the expression of dopamine-mediated behaviors? Pharmacol Biochem Behav 30:189-193.
55. Zappalà A, Cicero D, Serapide MF, Paz C, Catania MV, Falchi M, Parenti R, Panto MR, La Delia F, Cicirata F. 2006. Expression of pannexin1 in the CNS of adult mouse: Cellular localization and effect of 4-minopyridine- induced seizures. Neuroscience 141:167-178.